[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CMPX":3,"homepage-market-summary":30,"stock-news-CMPX":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"CMPX","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Compass Therapeutics, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.","39","Boston, MA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":19,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},0.8567,0.9401,0.9798,0.8294,0.9011,-0.0444,-4.93,20683854.749664,31225,0.902,6.88,4005663.20256666,0.5,1382,{"status":31,"indices":32,"watchlist":76,"sectors":98,"benchmarks":154},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":39,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":39,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":39,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":39},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":39},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":39},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":39},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":39},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":89,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},20,[175,181,187,192,198,204,209,215,220,226,232,237,243,247,251,256,260,266,272,276],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"$CMPX stock is down 13% today. Here's what we see in our data. - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiowFBVV95cUxQRThGazdKTkRPVEZVTkN6VHpILXZRa2VlOWkzbkluV2RlYXk1QXVhclFDbWY3UXpvM0tUUXpVdEZrVjVFQzRhSUFGRTZZVEdRbHJJcEhIQ2Y4Ykc2SVJSYjJfMzF4ZWpGRjJBS3VtOHJUZWMwR0lTaTFMQURNNTFHc3d2QlFVV0lyVHdDcUNJSExBemdmZlZsdzhXMjV6bkt4a3FB?oc=5","Thu, 01 Oct 2026 19:25:00 GMT","$CMPX stock is down 13% today. Here's what we see in our data. Quiver Quantitative","Quiver Quantitative",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Why Did Compass Therapeutics Stock Plunge Today? - Compass Therapeutics (NASDAQ:CMPX) - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1AFBVV95cUxNYlBGLXZXZTM3d3lMRlpFTWlsYU5OSFFlel82MlRVSU1MUmxQZ1RteE5TNzJLN1FaUUFOUUZTd1dfdXZzSU42WnF3eDJONFR6LXgtbDVOc3g1WHh3WmowZms5aDRJd3haTGZINGVXc1JHUlFnQmIyTVVCWGhSanVUUHZVOEZfZG45U2IwZndySTVNdHVYNnRjT1hzeHYwRno3YTFVZGlNN0FxWElnR20wYjdEWHF5TVAtQzNGVnAxbGVPTkVaaklrQjh6MUlvUTNNVzJqVw?oc=5","Tue, 22 Sep 2026 07:00:00 GMT","Why Did Compass Therapeutics Stock Plunge Today? - Compass Therapeutics (NASDAQ:CMPX) Benzinga","Benzinga",{"title":188,"link":189,"pubDate":184,"description":190,"source":191},"CMPX Stock Crashes To Over 2-Year Lows — Why FDA Wants Another Cancer Therapy Trial Before Key Marketing Filing - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMigwJBVV95cUxNSGlnLTVTTUNZVUFWZ0Y3c3lpMmktMVo0bWhvM3p2Mnh3NEtxdDdVbmR2V2VTY3hHaHVER0F6eWs5Z3llYnpLcHJPNkRTa1RDbE9XWnZvUmQtX1R2VXRyeGkzdzRfSl9YZkNOMlNoZEVMZE13amgyRjFSZ1NuZ0x6SmtiVzZDNUs3OFNwZTkxRXhDSjl2M3BzRVJLS1ZNWEJ5bW42UExHNHRGX1pEajlqMXNBWTdLRXpCRXNvZktTVWJUUmNlb2gtdVhmR09FYk03blRzUzZHRU83MmJWcTZxZms5enppYVFnMW9hLWJjakE5LTk3Tk00RG93U2luTVB0czF3?oc=5","CMPX Stock Crashes To Over 2-Year Lows — Why FDA Wants Another Cancer Therapy Trial Before Key Marketing Filing Stocktwits","Stocktwits",{"title":193,"link":194,"pubDate":195,"description":196,"source":197},"At $0.92 a share, Compass Therapeutics (CMPX) accounting chief buys 20,000 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxPa2J0TVl3Um44SW42TFpza19EX3lPMndObkEyTXJ4cjZwSTRQdVpfNjBBTGRTUDJ3aWdDeURwdVNpRXptSDA5NHZuaEFfRG5zYlAwSlpHcEYxMmItQjQ5Qkx0cHEwRUFuczFQbzZaLUhRbGJMdm5ybzc5dFNnU1I3ZFQ2ZG5HcGNpd252U0R1Wm83Z2ZNSVhiLTNfdjh0M3JiR3Vremx3UTQyLU9LRzhiZWdmYk92RXZjNFE?oc=5","Fri, 02 Oct 2026 12:05:20 GMT","At $0.92 a share, Compass Therapeutics (CMPX) accounting chief buys 20,000 shares. Stock Titan","Stock Titan",{"title":199,"link":200,"pubDate":201,"description":202,"source":203},"Compass Therapeutics stock downgraded at Wedbush (CMPX:NASDAQ) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiiwFBVV95cUxOMURleTh5MlhQUDBjeUk0UUhXQ1pzZFdLMGJ1aEVzeXJoZC12SUE5aVFuaFJxbVQ1a2lFVDhYbVNqZWtHd05GeFpkTzY3WWwySGk4dGt6R0d1dXlZelN0T3Bjc25aUjFxZmszd3ZvR0F2Y0k0RnVYYUhlSUdvYlVCQ0d0MC1PUW9ZX0pj?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Compass Therapeutics stock downgraded at Wedbush (CMPX:NASDAQ) Seeking Alpha","Seeking Alpha",{"title":205,"link":206,"pubDate":201,"description":207,"source":208},"Compass Therapeutics Shares Drop After Downgrade From Wedbush - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqwFBVV95cUxOUmd4NzZrek5PcHZQQ2FYaXJqMGk5WnNDRm9sZXZGYU5Hd3VocWxKeWJKbVdwSlNLZDNZMzJNeG5hTUZJSXpfY1BOU1BDUTJQXzgzdHIxaWtFQnotSHBVbUJ4VTl0NUhhSzlxa3NCX0ljc1VhV25ISW95eUVab0R0dTBVRDlacVJRcUlWUHVtVjBUbU5lTTR3QXI0MDRhNFQ5cmdNZGh0TEduamc?oc=5","Compass Therapeutics Shares Drop After Downgrade From Wedbush Yahoo Finance","Yahoo Finance",{"title":210,"link":211,"pubDate":212,"description":213,"source":214},"Compass Therapeutics CAO Neil Lerner buys $2,849 in CMPX shares - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxOb2Rfd0w4b3E2SWQ4UXY0dTVmWmNkemIwcjdwN2Z6d3pKalVoMzJBdnNFM2pxam45WTdZSXRhZE9sdDNxbmlaOEFJRTE0ZXRwX29lcGhsakIyTTRUbGxGU0xFY2kzVkZ0UXZBRnVGOVNxaUxLOE5fSzh1bW9lUTE0aG1iWDMyQU5XR0JSbk5sVjVBOXRZOGFrclVFTG9LY1I5M19vZXV0NkpQNWlQSFZib1l4OUZua055UGI0cklMRjExbGRZ?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","Compass Therapeutics CAO Neil Lerner buys $2,849 in CMPX shares Investing.com","Investing.com",{"title":216,"link":217,"pubDate":201,"description":218,"source":219},"Compass Therapeutics’ FDA Setback Raises Concerns On Wall Street — H.C. Wainwright Calls Tovecimig Filing Strategy ‘Risky’ - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiiAJBVV95cUxPQlR0aDEyb012UUw4aW55c0xWVlU3T05VQXVkcWxGMklEalloRE55TFVfakZla2tacTlPMjhEX0NEZUpPbklTUHU3SEdCLWZyTWxHY1dDYXFSMEJNTE8zWXdsaVB2MXlkM2h1ZmhGVFA4b1ByNGRTYUt1NUh1SlZ5S2N3VkdOQjZteXM3TF95Wml2aThxNDZiYWd6eDFIblg2R3JXV3AxNkhvbHBENThjc0owaVByZjlDSmNkakthVFhiX0ZndFBHdE1WOHk3WVllU0x0LUJPOGlHdzFsSVE3dnpWeS1ZN2NKVFdEMW1tTVZNM2s5M05Mcl9lRFMybHdPSG10ZDBmdWE?oc=5","Compass Therapeutics’ FDA Setback Raises Concerns On Wall Street — H.C. Wainwright Calls Tovecimig Filing Strategy ‘Risky’ TradingView","TradingView",{"title":221,"link":222,"pubDate":223,"description":224,"source":225},"Compass Therapeutics (CMPX) Insider Buy: Chief Accounting Officer Neil Lerner Purchases 2,500 Shares - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0AFBVV95cUxNQ1IzeXJ6Nm9CQTBqUVdJdE5IMjRFZzZSZ3FpZTlVNDVUVDQydjFhMGc3ZFlYX1ZpeVJEeHZsV2JyYXZpdFg3ZFh2b01sYnl4aTlPdWdlclVYbWZTd2k2YW0xVXgxTmJDS2hyNk5uT3ZnTnVta0lmdGtxZGdzZ01UclU3djN5cW5md2U3cVhqaHNkMmRwVl9INjRNU25yN2JQVUozNnNDeVk4RzJQdVJDWnE5WHh2VDdZdTN6TmVObXZzNnp0TjYwSFI5OHZHS282?oc=5","Fri, 25 Sep 2026 14:30:56 GMT","Compass Therapeutics (CMPX) Insider Buy: Chief Accounting Officer Neil Lerner Purchases 2,500 Shares GuruFocus","GuruFocus",{"title":227,"link":228,"pubDate":229,"description":230,"source":231},"Compass shares fall after FDA tovecimig feedback - grafa.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxNNWJZUElSS3ljbTZkQm5pbEg3aDhMWnRPdEhMaFhrQkVoblF5dzNzakt2dDloek9KNGlNY3BGOFhkMV8wSE9kZ3pWRjhXNFdQRXFlUjM1MWNNcFFmQl91QmI5b2l3RW5NeEV3REtteWZoQnI3RFBLVEFxTXhrSy1kM29IcXJIaWRiTV8xZzhGMFJoZw?oc=5","Tue, 22 Sep 2026 17:32:00 GMT","Compass shares fall after FDA tovecimig feedback grafa.com","grafa.com",{"title":233,"link":234,"pubDate":235,"description":236,"source":197},"After buying 2,500 shares, Compass Therapeutics (CMPX) accounting chief reports a 400,000-share position - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxObnBCVExHS01uWTBHWENVWXJTanBLb21WOHNYYURHejktRWgzUE0tVE13cHZFQ0tqb084VDY5a1p0ZE1WYXd6dHNlZ0xtZHBpWlozT1VCeTAzTVlWUk9rRWFGNURkVVhtTlE3Rl9LeWZBajBzSDZPcm1udlVXWHotM0RhWTc0aGhUb3E2TUVKNDRIeUtnQ3otYTVacnNRWVBlVGtiZGVjcEtRME02TVZpeXA2X0FXTHBOV0E?oc=5","Fri, 25 Sep 2026 12:02:27 GMT","After buying 2,500 shares, Compass Therapeutics (CMPX) accounting chief reports a 400,000-share position Stock Titan",{"title":238,"link":239,"pubDate":240,"description":241,"source":242},"Is Compass Therapeutics, Inc. (CMPX) the Healthcare Stocks Stock Everyone's About to Talk About? - Kalkine Media","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0gFBVV95cUxPeC1DM3BCaUFqZnhXM19NMnBnVUduT3FHbkJWM2RZenJRdG5qOWUwdWZDNnRlR1oweGdoR3dyZHV0R1dDallxLVNkbjZhVF9wUFVSeHpIdE16S3BJNC1kb01nUXA2REZpeFlpd2tkMGc1TDJFc0pPb0lhRGlFdy1sRnVGckVqZjRpT0RfQ2dReHhmb1ozRlVKOFl4VVFyWUR1UkI0dkpaNmdVMzJlQkJZdkg5QXAwa0FVZkNSN2JqUmJyc0Zxb3l0Y3hxbk1LbmFxREE?oc=5","Fri, 25 Sep 2026 12:30:00 GMT","Is Compass Therapeutics, Inc. (CMPX) the Healthcare Stocks Stock Everyone's About to Talk About? Kalkine Media","Kalkine Media",{"title":244,"link":245,"pubDate":184,"description":246,"source":208},"CMPX Plunge Wipes Out $104M After FDA Demands Fresh Trial For Cancer Drug — Wedbush Sees Another 19% Downside - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikAFBVV95cUxPYWp2X0R0TWhQUUdycTRDOWd6QWVvOTlCOElWTlFrVEIzWjN5N2VwUEdPWWdINU8wRzJxQkNyeTdWaEJYb2dfaDlfOHBaUnhuQWw5OUZnUUdVcHpWT2oxTE9UTlA0SU9TNFItMVNIOVB1ZlRvYXdYQnpxMFV4UVktVi1PcWNQVUFhekg5NHFfSlg?oc=5","CMPX Plunge Wipes Out $104M After FDA Demands Fresh Trial For Cancer Drug — Wedbush Sees Another 19% Downside Yahoo Finance",{"title":248,"link":249,"pubDate":201,"description":250,"source":203},"Compass Therapeutics: A Promising, But Shrinking, Window Of Opportunity (NASDAQ:CMPX) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirgFBVV95cUxQMG1yay1uMmk3bkg4TkRhcHUzSTF0dk92bzg2LTRnWExNR1FrTVVDdTdlZTUwVGM2ZlVEa2dxanBiUnAxV3VNMkJmWl81elJ0ZUNsMktNZ1VBN0FWTTdzeTdXNjd5SFQydUN6WWxTR2tHMmZ2VDhiZ1pncE1yT1h4MzVXT1A5THhHWEJLZUluRzNnSXF3SXl4UDFmcTlJbjJCN3lVR2w1SWlYY2x0T1E?oc=5","Compass Therapeutics: A Promising, But Shrinking, Window Of Opportunity (NASDAQ:CMPX) Seeking Alpha",{"title":252,"link":253,"pubDate":254,"description":255,"source":191},"Compass Therapeutics’ FDA Setback Raises Concerns On Wall Street — H.C. Wainwright Calls Tovecimig Filing Strategy ‘Risky’ - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijAJBVV95cUxNbXZ3S3N2dkJxZVlDT3Q1V1hacjcwQmFOc3pONHNrUWJQSUs2ZjhJU3g3SUVlU2t0NUozN0NldGFadGRuVW9lTVBWUktKeHhxZUV6SFhOSjRNOGNURVVWaFBURHdQQ2MyNTNHRXg2bW9samh1UzBwOTVxcE9SWTZIYVhFV2RCNERTT3BaNGt6NkdOWTVqa3NHRVhvXzZzQ0lpSzFMRlZTUDU4WV9nVFFjbEJxdTlMQTJLSWdaQWgwUF96YU5XRGJSMWJ5TnZrbF9BbGMyRFEybWduSlVSbkpEbUgxMHFsNEJGd2dKR2NOQi1XYnFUaVVLanhHVUZYVTlocHJkTTQzRWJmRkI2?oc=5","Wed, 23 Sep 2026 13:46:04 GMT","Compass Therapeutics’ FDA Setback Raises Concerns On Wall Street — H.C. Wainwright Calls Tovecimig Filing Strategy ‘Risky’ Stocktwits",{"title":257,"link":258,"pubDate":184,"description":259,"source":197},"The FDA recommended a trial to show patients live longer. Compass says its current study is enough. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxPRG1CZVhXTFp1RjVMaWJQY1NRQ2N2eUtTcFlsZzJpN1RzQ0pmY0stMXIwZHBKNXVGZ0ZZeG1TeTVZUk5hcldTVlNiei02ZmV5V0FocGFTYzlONXktaDdrZHU0aU02VGVZd1I4SUtJU04xaTZ4UWlJTzZibUREWENBMHVhQXZKb05kSDA4Vm9TOEJVenZmQWxUeVJqa09kRkN2NV9BZ0xjNWFfMEVqVzRKbDJXcm1laUZXMnc?oc=5","The FDA recommended a trial to show patients live longer. Compass says its current study is enough. Stock Titan",{"title":261,"link":262,"pubDate":263,"description":264,"source":265},"Compass Therapeutics CAO Neil Lerner buys $18,400 in company shares By Investing.com - Investing.com Nigeria","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxOMFAyYnZQQzlmLVZCdkhFc0hzand5Zm80UVJjd3FiRWtTNUZBVzg1VkRJb3dkS1RKeEJNNi1PdEhPaTJLUUh6ZGN3TWJnblBrQUxwamhfUzB5emQ5N0YwM0R4OTRuSmNSb3dTNzJDTmRFZ1pwdGYtdjBnUjhvRGZ5aXM0QVcxUjBZUTYxclk5QUxXOTY5U0RLdmQ5cVJpSGh6Z0VEWk5XeWwzeFVySzlKSGhiVnladjhsaDkzYWxiYWJ2MlhM?oc=5","Fri, 02 Oct 2026 13:25:31 GMT","Compass Therapeutics CAO Neil Lerner buys $18,400 in company shares By Investing.com Investing.com Nigeria","Investing.com Nigeria",{"title":267,"link":268,"pubDate":269,"description":270,"source":271},"CMPX Feb 2027 1.500 put (CMPX270219P00001500) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTFBXdTJIYnFXdUQ3T21nNXp3R3U0bjZ6dVRFWXZBZERWQUdxRVZKaElEcm41b1UyTE1kX1hNT1dIRHhuSmJESmloelcydTRHU0E3Q3hiSnNlaW5kUmd0blRETnJtOW5kUQ?oc=5","Sun, 04 Oct 2026 02:29:12 GMT","CMPX Feb 2027 1.500 put (CMPX270219P00001500) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":273,"link":274,"pubDate":184,"description":275,"source":203},"Compass says FDA seeks additional trial for lead asset (CMPX) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxNWHRyRzhOaEFBSUlHaEdxNDZ4ME0wZzI3N3RFb3pzcFlIWVdrOWxzT1g4enZOS3o0NmN5ejh6WUhUZTFKRUlZRy1ERXJRSl9XOWwxd0hzSUR1VTN3Mnk0NWRmQTRFeFV5U2dNazRYeU0zeGcydS1JYkxVZElNRTFqNHJTbnhPeHZ2SElfU09CeHRFdw?oc=5","Compass says FDA seeks additional trial for lead asset (CMPX) Seeking Alpha",{"title":277,"link":278,"pubDate":201,"description":279,"source":208},"Wedbush Downgrades Compass Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $5 - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxPalZqTk1BV1UtanR2alNYS044ajk4UVREeHBHSjlsQ3dhT19XMW5QN1BSbVltdkFpc0dCWHFxNnJVdDJhcHZhTE1lNkpTRjJHR2tWNk9NYmdHRE42U3VDQVVVSjhueGxMZmNaSndZNlJVU0llS2R4RG5KRDdCdEgydF9qTEEzeG9RVFNIVllpS1F3QV8yeFloVU5PRjRJSElMMUpYRExjT05CdWxZeHFSTE93?oc=5","Wedbush Downgrades Compass Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $5 Yahoo Finance"]